Opening: Direct Answer (Module A)
In Vitro Fertilization (IVF) is a mature assisted reproductive technology. The core process involves combining a woman's egg with a man's sperm outside the body to form an embryo, which is then transferred back into the uterus. Based on fertilization methods and clinical needs, it is categorized into First-generation IVF (conventional in vitro fertilization), Second-generation ICSI (Intracytoplasmic Sperm Injection), and Third-generation PGT (Preimplantation Genetic Testing). In China, this technology is integrated into the standard medical system, with hundreds of thousands of cycles performed annually.
Who is Suitable for IVF?
IVF has clear medical indications. Not all infertility cases require immediate IVF. The following situations, after medical evaluation, are suitable for starting IVF treatment:
- Female Tubal Factor: Blocked fallopian tubes, severe adhesions, hydrosalpinx, or post-tubal removal, preventing natural meeting of sperm and egg.
- Ovulation Disorders: Polycystic ovary syndrome (PCOS), luteinized unruptured follicle syndrome (LUFS), etc., with no pregnancy after 3-6 cycles of ovulation induction.
- Moderate to Severe Endometriosis: Affecting egg quality, tubal function, or the pelvic environment.
- Male Factor: Oligospermia (concentration < 15 million/mL), asthenospermia (progressive motility < 32%), teratospermia (normal morphology < 4%), or obstructive azoospermia.
- Unexplained Infertility: No abnormalities found in routine examinations for the couple, but no pregnancy after 3 or more intrauterine inseminations (IUI).
- Genetic Diseases: Need for PGT to screen for healthy embryos, preventing single-gene disorders or chromosomal structural abnormalities.
Who is Not Suitable for IVF?
- Women with severe heart, liver, or kidney disease, or uncontrolled diabetes or hypertension, posing extremely high pregnancy risks.
- Severe uterine malformation, severe intrauterine adhesions, or irreparable endometrial damage preventing normal embryo implantation.
- Uncontrolled thyroid dysfunction (hyperthyroidism or hypothyroidism), active infectious diseases (e.g., active hepatitis B, tuberculosis).
- Severe mental illness in either partner, making it impossible to cooperate with treatment or assume parenting responsibilities.
- Either or both partners have substance abuse or alcoholism issues that have not been resolved.
Complete IVF Process
A standard IVF cycle is divided into seven stages, each with specific tasks and timelines.
Stage 1: Pre-treatment Tests
Both partners must undergo systematic tests to assess physical condition and fertility potential.
- Female Tests: Basal endocrine hormones (FSH, LH, E2, Progesterone, Testosterone), AMH, Antral Follicle Count (AFC), Thyroid function (TSH, FT3, FT4), Infectious disease screening (Hepatitis B, Hepatitis C, HIV, Syphilis), Karyotype analysis, Complete blood count (CBC), Coagulation profile, Electrocardiogram (ECG). Some patients may require a hysteroscopy.
- Male Tests: Semen analysis (concentration, motility, morphology, DNA fragmentation index), Infectious disease screening, Karyotype analysis, Complete blood count (CBC).
Pre-treatment tests typically take 1-2 weeks to complete. Note that some tests have validity periods: infectious disease screening is valid for 6 months, while karyotype analysis is valid for life.
Stage 2: File Creation & Protocol Determination
Once all test results are available, the couple brings their ID cards and marriage certificate to the fertility center to create a medical file. For IVF within China, an ID card and marriage certificate are sufficient; for overseas IVF, a passport and visa are also required.
The doctor determines an individualized ovarian stimulation protocol based on the woman's age, AMH, antral follicle count, and medical history. A comparison of common protocols is shown below:
| Protocol Type | Suitable Candidates | Cycle Duration | Key Features |
|---|---|---|---|
| Long Protocol | Normal ovarian function | ~4 weeks | Down-regulation starts 7-10 days before menstruation; good follicular synchrony |
| Short Protocol | Older age or poor ovarian response | ~2 weeks | Direct stimulation start; high flexibility |
| Antagonist Protocol | PCOS, high responders | ~2 weeks | Flexible suppression of premature LH surge; low OHSS risk |
| Mini-Stimulation Protocol | Low ovarian reserve, low AMH | ~10 days | Low medication dose; fewer eggs retrieved but potentially better quality |
Stage 3: Ovarian Stimulation
Ovarian stimulation medications (e.g., recombinant FSH, HMG, Letrozole) are used to promote the synchronized development of multiple follicles. During this period, the patient returns to the clinic every 2-3 days for monitoring of follicle growth and hormone levels. The medication dosage is adjusted based on the response. This phase lasts 10-14 days. When the leading follicles reach 18-20mm in diameter, a trigger shot of hCG or GnRH agonist is administered.
Stage 4: Egg Retrieval & Sperm Collection
34-36 hours after the trigger shot, eggs are retrieved via transvaginal ultrasound-guided aspiration. The procedure takes about 15-20 minutes under general or local anesthesia. The male partner provides a semen sample on the same day. Men with difficulty producing a sample can freeze sperm in advance.
Stage 5: Embryo Culture
Eggs and sperm are combined in the laboratory and cultured for 3-6 days. Day 3 embryos are at the cleavage stage, while Day 5-6 embryos are blastocysts. If PGT is required, 3-5 trophectoderm cells are biopsied from the blastocyst for genetic testing, which takes approximately 2-4 weeks.
Stage 6: Embryo Transfer
1-2 high-quality embryos are selected and transferred into the uterus. The procedure takes about 5-10 minutes and requires no anesthesia. Remaining embryos can be frozen (frozen embryos) for future transfers.
Stage 7: Luteal Support & Pregnancy Test
After the transfer, progesterone medications (injections, oral, or vaginal gel) are used to support luteal function. A blood test for β-hCG is performed 12-14 days after the transfer to determine if pregnancy has occurred.
Timeline
A complete IVF cycle typically takes 2-3 months. The specific breakdown is as follows:
| Stage | Time Required | Notes |
|---|---|---|
| Pre-treatment Tests | 1-2 weeks | Some tests must be done on Day 2-3 of menstruation |
| Ovarian Stimulation | 10-14 days | Requires 6-8 monitoring visits |
| Egg Retrieval | 1 day | Can leave hospital 2-4 hours after procedure |
| Embryo Culture | 3-6 days | Blastocyst culture takes 5-6 days; PGT adds 2-4 weeks |
| Embryo Transfer | 1 day | No hospitalization required after transfer |
| Pregnancy Test | 12-14 days post-transfer | Continue luteal support during waiting period |
If pregnancy is not achieved after the transfer, it is recommended to wait 2-3 menstrual cycles before a frozen embryo transfer. Throughout the cycle, the woman needs to invest significant time and effort, so it is advisable to plan work and personal schedules in advance.
Test Result Interpretation
The following indicators are key for assessing fertility potential and determining treatment protocols. Understanding their meaning helps you grasp your own situation.
AMH (Anti-Müllerian Hormone)
Secreted by granulosa cells of ovarian antral follicles, reflecting ovarian reserve. Normal range: 1.5-7 ng/mL. AMH < 1 indicates diminished reserve, < 0.5 indicates severely diminished reserve. High AMH (>7) is common in PCOS. Low AMH does not mean IVF is impossible; it simply means fewer eggs can be retrieved, and a mini-stimulation protocol is a common choice.
FSH (Follicle-Stimulating Hormone)
Basal FSH (measured on Day 2-3 of menstruation) normal range: 5-10 mIU/mL. FSH > 10 suggests diminished ovarian function, > 15 indicates poor response, > 20 generally means using one's own eggs is not recommended.
LH (Luteinizing Hormone)
Basal LH normal range: 3-12 mIU/mL. An LH/FSH ratio > 2 may indicate PCOS.
Antral Follicle Count (AFC)
Ultrasound count of total antral follicles (2-10mm) in both ovaries on Day 2-3 of menstruation. Normal: > 10 follicles. 5-10 indicates diminished reserve. < 5 indicates severely diminished reserve.
Semen Analysis
WHO 5th edition standards: Concentration ≥ 15 million/mL, progressive motility ≥ 32%, normal morphology ≥ 4%. Sperm DNA fragmentation index (DFI) < 30% is normal. High DFI can affect embryo development and implantation.
Factors Affecting Cost
The cost of a single IVF cycle in China ranges from 30,000 to 80,000 RMB, varying based on the following factors:
| Factor | Cost Difference | Explanation |
|---|---|---|
| Geographic Location | Difference of 10,000-20,000 RMB | Costs in first-tier cities like Beijing, Shanghai, Guangzhou are generally higher than in second and third-tier cities |
| Hospital Type | Difference of 10,000-30,000 RMB | Private fertility centers charge more than public tertiary hospitals, but may offer more streamlined services |
| Stimulation Medications | Difference of 3,000-8,000 RMB | Imported drugs (e.g., Gonal-F, Puregon) are more expensive than domestic ones (e.g., Lishenbao) |
| Technology Type | ICSI adds 3,000-5,000 RMB | ICSI involves an additional cost for intracytoplasmic sperm injection compared to conventional IVF |
| PGT Testing | Additional 20,000-40,000 RMB | Charged per embryo for biopsy and genetic testing |
| Number of Transfers | Each frozen embryo transfer costs ~10,000-20,000 RMB | Total cost accumulates if multiple transfers are needed |
| Donor Sperm (Male) | Adds sperm bank fees | Approximately 3,000-6,000 RMB |
IVF costs abroad are generally higher than in China, mainly due to exchange rates, airfare, accommodation, and agency fees, but the specific amount varies greatly depending on the country and treatment plan.
Differences by Age Group
The woman's age is the most critical factor affecting IVF success rates, primarily reflected in the decline of egg quantity and quality with age.
| Age | Live Birth Rate per Cycle | Recommended Strategy |
|---|---|---|
| < 35 years | 50-60% | Standard protocol; no special preparation needed; single embryo transfer reduces multiple pregnancy risk |
| 35-37 years | 40-45% | Advise to proceed promptly; consider PGT for selecting optimal embryos |
| 38-40 years | 25-35% | Comprehensive ovarian function assessment needed; may require multiple cycles to accumulate embryos |
| 40-42 years | 15-20% | Mini-stimulation protocol is safer; egg donation may also be considered |
| > 42 years | < 10% | Natural cycle or mini-stimulation; egg donation is a more favorable option |
If the male partner is over 40 years old, sperm DNA fragmentation index may be elevated. It is recommended to check this and consider targeted interventions in advance.
Easily Overlooked Details
The following aspects are often neglected during IVF preparation but can potentially impact the outcome:
- Thyroid Function: TSH > 2.5 mIU/L is associated with lower implantation rates. It is recommended to keep TSH between 1.5-2.5. Hyperthyroidism or hypothyroidism should be stabilized before starting a cycle.
- Vitamin D Levels: Vitamin D deficiency is linked to diminished ovarian function and reduced endometrial receptivity. Supplementation to achieve levels > 30 ng/mL is advised.
- Uterine Cavity Environment: Intrauterine adhesions, polyps, submucosal fibroids, and chronic endometritis can affect implantation. Hysteroscopy is recommended before transfer, especially for those with repeated implantation failure.
- Immunological Factors: Abnormalities in antiphospholipid antibodies, natural killer cell activity, or blocking antibodies require evaluation by a reproductive immunology specialist.
- Psychological State: Chronic anxiety and stress can elevate cortisol, suppress sex hormone secretion, and affect follicular development and endometrial receptivity. Psychological counseling or mindfulness training during treatment is recommended.
- Weight Management: Both BMI > 28 and BMI < 18.5 reduce live birth rates. It is recommended to maintain a BMI between 19-24.
Frequently Asked Questions (FAQs)
Observations from Practitioners
In our work at the fertility center, we have observed the following patterns that substantially impact IVF outcomes:
- Individualized protocols are more important than template-based approaches. Different patients respond very differently to the same medication. Doctors need to dynamically adjust based on follicular growth rate and hormone levels, rather than rigidly following a fixed protocol.
- Embryo quality is more critical than quantity. The implantation potential of one good-quality blastocyst is higher than that of three average cleavage-stage embryos. For patients with a high blastocyst formation rate, single embryo transfer can significantly reduce multiple pregnancy risks.
- Psychological resilience affects treatment outcomes. Patients with a stable mindset and good compliance have higher completion rates for ongoing treatment and ultimately a higher probability of achieving pregnancy. It is recommended that patients set realistic expectations and avoid excessive anxiety over a single success or failure.
- Male factors are often underestimated. Indicators like sperm DNA fragmentation index and sperm nuclear maturity significantly impact embryo development and implantation. Male partners should actively cooperate with testing and interventions.
- Laboratory standards determine embryo potential. Different fertility centers have varying culture systems, operational experience, and quality control standards, which directly affect blastocyst formation rates and embryo quality. When choosing a center, it is advisable to look into its laboratory background.
Doctor's Advice
For couples planning IVF, it is recommended to start systematic preparation 3 months in advance. The woman should focus on folic acid supplementation, regulating sleep patterns, and weight control. The man should quit smoking and alcohol, and avoid prolonged sitting and high-temperature environments. When choosing a fertility center, pay attention to its clinical experience and laboratory standards, rather than just the advertised success rates.
During treatment, maintain realistic expectations—the live birth rate per cycle is not 100%, but the cumulative pregnancy rate increases with the number of transfers. If the first transfer fails, work with your doctor to analyze the reasons (embryo, endometrial, immune, coagulation factors, etc.) and make targeted adjustments before trying again.
Finally, assisted reproduction is a path that requires patience and a scientific approach. We encourage couples to support each other and make decisions together. Wishing you all the best.
Comments (0)